RICHMOND, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced that the company and its collaborators will exhibit their Ekso GT robotic exoskeleton in New Orleans at both the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly taking place October 20-23, 2016 and the American Medical Rehabilitation Providers Association (AMRPA) Annual Educational Conference taking place October 24-26, 2016.
Ekso Bionics will host a symposium in conjunction with AAPM&R on Friday, October 21 from 4:45 – 6:00 pm at the New Orleans Downtown Marriott Convention Center. During this symposium, Dr. Jeffrey Oken, Chief Medical Officer at Marianjoy Rehabilitation Hospital and Dr. Christina Kwasnica, Medical Director of Neuro-rehabilitation at Barrow Neurological Institute will discuss their research on the use of Ekso GT. In addition, Leslie VanHiel, DPT and Clinical Training Specialist at Ekso Bionics will review the most recent studies involving the Ekso GT device. A demonstration and Q&A will follow the symposium.
There are four educational sessions at AAPM&R dedicated to robotic therapy:
Session 401. Integrating Advanced Rehabilitation Technology and Robotics into Clinical Practice
7:30 AM–9:00 AM Oct 20, 2016; Convention Center, Meeting Room R08-09, Level 2
Erin Eggebrecht, PT, DPT, NCS
Deborah Gaebler-Spira, MD, McGaw Medical Center of Northwestern University (RIC) PM&R Program
Joshua Vova, MD
Session W204. Incorporating Exoskeletal Robots Into Practice
2:00 PM–3:30 PM Oct 20, 2016; Convention Center, Meeting Room 217, Level 2
Lauri Bishop, PT, DPT
Alberto Esquenazi, MD, Chmn Dept of PMR and Chief Med Off at Moss Rehab Hosp
Kristen Hohl, MD
Casey Kandilakis, PT, DPT, NCS
Donald Leslie, MD, Shepherd Ctr
Joel Stein, MD, Chair at Columbia Univ Med Ctr
Session 223. Frontiers in Rehabilitation Robotics
2:30 PM–4:00 PM Oct 22, 2016; Convention Center, Great Hall B, Level 1
Sunil Agrawal, PhD
Ethan Rand, MD, Assistant Professor at New York Prebyterian – Weill Cornell Medicine
Joel Stein, MD,Chair at Columbia Univ Med Ctr
Session 225. Robotics in Rehabilitation: Optimizing Treatment Delivery
4:15 PM–5:45 PM Oct 22, 2016; Convention Center, Great Hall B, Level 1
Alberto Esquenazi, MD, Chmn Dept of PMR and Chief Med Off at Moss Rehab Hosp
Matthew Vnenchak, PT
The following educational session will be offered at AMRPA:
Robotics in Neurorehabilitation: A Way to Improve Care Intensity and Efficiency
4:50 PM-5:50 PM Oct. 24, 2016; Royal Sonesta Hotel, Royal Conti Room
Alberto Esquenazi, MD, Chmn Dept of PMR and Chief Med Off at Moss Rehab Hosp
Ekso Bionics will be exhibiting at booth numbers 201 for AAPM&R and 18 for AMRPA.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: www.eksobionics.com.
About Ekso™ GT
Ekso™ GT is the first FDA cleared exoskeleton cleared for use with stroke and spinal cord injuries from L5 to C7. The Ekso GT with smart Variable Assist™ (marketed as SmartAssist outside the U.S.) software is the only exoskeleton available for rehabilitation institutions that can provide adaptive amounts of power to either side of the patient’s body, challenging the patient as they progress through their continuum of care. The suit’s patented technology provides the ability to mobilize patients earlier, more frequently and with a greater number of high intensity steps. To date, this device has helped patients take more than 55 million steps in over 120 rehabilitation institutions around the world.
